NFKB SIGNALING PATHWAY AS A THERAPEUTIC TARGET IN CHEMORESISTANT OVARIAN CANCER

被引：0
|
作者：
Yousefi, H. [1 ]
Momeny, M. [1 ]
Poursheykhani, A. [1 ]
Ghaffari, S. H. A. [1 ]
Eyvani, H. [1 ]
Zarrinrad, G. [1 ]
Barghi, F. [1 ]
Sabourinejad, Z. [1 ]
Esmaili, F. [1 ]
机构：
[1] Univ Tehran Med Sci, Med Genet, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0016
引用
收藏
页码：1727 / 1727
页数：1
相关论文
共 50 条
  • [1] Hedgehog signaling pathway as a therapeutic target for ovarian cancer
    Li, Haixia
    Li, Jinghua
    Feng, Limin
    [J]. CANCER EPIDEMIOLOGY, 2016, 40 : 152 - 157
  • [2] IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer
    Yousefi, Hassan
    Momeny, Majid
    Ghaffari, Seyed H.
    Parsanejad, Nazanin
    Poursheikhani, Arash
    Javadikooshesh, Sepehr
    Zarrinrad, Ghazaleh
    Esmaeili, Fatemeh
    Alishahi, Zivar
    Sabourinejad, Zahra
    Sankanian, Ghazaleh
    Shamsaiegahkani, Sahar
    Bashash, Davood
    Shahsavani, Narjes
    Tavakkoly-Bazzaz, Javad
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    [J]. TUMORI JOURNAL, 2019, 105 (01): : 84 - 91
  • [3] CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
    Feng, Xiaojie
    Bai, Xupeng
    Ni, Jie
    Wasinger, Valerie C.
    Beretov, Julia
    Zhu, Ying
    Graham, Peter
    Li, Yong
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [4] CHTOP is a novel therapeutic target for chemoresistant epithelial ovarian cancer therapy
    Bai, Xupeng
    Feng, Xiaojie
    Ni, Jie
    Beretov, Julia
    Deng, Junli
    Zhu, Ying
    Graham, Peter
    Li, Yong
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [5] BMP signaling is a therapeutic target in ovarian cancer
    Fukuda, Tomohiko
    Fukuda, Risa
    Tanabe, Ryo
    Koinuma, Daizo
    Koyama, Hiroo
    Hashizume, Yoshinobu
    Moustakas, Aristidis
    Miyazono, Kohei
    Heldin, Carl-Henrik
    [J]. CELL DEATH DISCOVERY, 2020, 6 (01)
  • [6] BMP signaling is a therapeutic target in ovarian cancer
    Tomohiko Fukuda
    Risa Fukuda
    Ryo Tanabe
    Daizo Koinuma
    Hiroo Koyama
    Yoshinobu Hashizume
    Aristidis Moustakas
    Kohei Miyazono
    Carl-Henrik Heldin
    [J]. Cell Death Discovery, 6
  • [7] Purinergic signalling pathway: therapeutic target in ovarian cancer
    Nisha Chandran
    Mahalaxmi Iyer
    Zothan Siama
    Balachandar Vellingiri
    Arul Narayanasamy
    [J]. Egyptian Journal of Medical Human Genetics, 21
  • [8] Purinergic signalling pathway: therapeutic target in ovarian cancer
    Chandran, Nisha
    Iyer, Mahalaxmi
    Siama, Zothan
    Vellingiri, Balachandar
    Narayanasamy, Arul
    [J]. EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2020, 21 (01)
  • [9] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    HaiXia Li
    JianFang Zeng
    Keng Shen
    [J]. Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078
  • [10] Neurotensin signaling pathway as a potential therapeutic target in high-grade serous ovarian cancer
    Norris, E. J.
    DeStephanis, D.
    Zhang, Q.
    Tait, D. L.
    Ganapathi, R.
    Ganapathi, M.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 71 - 71
12345